RET-mediated CD44 proteolysis promotes autonomous proliferation of thyroid cells

Tamburrino, Anna (2008) RET-mediated CD44 proteolysis promotes autonomous proliferation of thyroid cells. [Tesi di dottorato] (Inedito)

Full text disponibile come:

[img]PDF (TESI DI DOTTORATO) - Solo per gli Amministratori dell'archivio fino a Novembre 2012 - Richiede un editor Pdf del tipo GSview, Xpdf o Adobe Acrobat Reader
9Mb

Abstract

This dissertation addresses signaling mechanisms involved in thyroid carcinoma formation, with a view of identifying novel levels for therapeutic intervention. In this frame, appended manuscripts II, III and IV focus on the functional characterization of a novel BRAF mutation and on molecular targeting of RET or BRAF pathways in thyroid cancer. The main body of the dissertation describes a novel signaling mechanism that we have identified in thyroid carcinomas harboring BRAF or RET/PTC oncogenes and that involves CD44. CD44, a cell surface adhesion molecule overexpressed in a wide range of cancer types, undergoes sequential proteolytic cleavage at the extracellular and intramembrane domains. This results in the shedding of the ectodomain (ectoCD44) and in the intracellular release of an intracellular fragment (CD44-ICD). CD44-ICD is translocated to the nucleus and activates gene transcription. Our group has previously demonstrated that CD44 is overexpressed in papillary thyroid carcinoma (PTC) tissue samples and in cell lines harboring RET/PTC or BRAF oncogenes. Here, we show that RET/PTC signaling induces γ-secretase-dependent CD44 proteolysis through the ERK pathway. Chemical blockade of either RET/PTC or MEK abrogates CD44 cleavage. Adoptive overexpression of CD44-ICD stimulates TSH-independent proliferation of thyroid follicular PC cells. CD44-ICD binds to CREB and stimulates CREB-mediated transcription in PC cells by potentiating CREB S133 phosphorylation. Through this mechanism, CD44-ICD up-regulates cyclin D1 expression and proliferation of thyroid cells. Taken together, these findings suggest that ERK kinase pathway-mediated CD44 cleavage sustains proliferation of thyrocytes harboring RET/PTC, RAS or BRAF oncogenes. This novel pathway may provide new molecular targets for therapeutic intervention in thyroid carcinoma.

Tipologia di documento:Tesi di dottorato
Parole chiave:oncogenes, thyroid tumors, RET, CD44, CREB,
Settori scientifico-disciplinari MIUR:Area 06 Scienze mediche > MED/04 PATOLOGIA GENERALE
Coordinatori della Scuola di dottorato:
Coordinatore del Corso di dottoratoe-mail (se nota)
Vecchio, Giancarlovecchio@unina.it
Tutor della Scuola di dottorato:
Tutor del Corso di dottoratoe-mail (se nota)
Santoro, Massimomasantor@unina.it
Stato del full text:Inedito
Data:01 Dicembre 2008
Numero di pagine:150
Istituzione:Università degli Studi di Napoli "Federico II"
Dipartimento o Struttura:BIOLOGIA E PATOLOGIA CELLULARE E MOLECOLARE
Tipo di tesi:Dottorato
Stato dell'Eprint:Inedito
Scuola di dottorato:MEDICINA MOLECOLARE
Ciclo di dottorato:XXI
Numero di sistema:3223
Depositato il:11 Novembre 2009 11:29
Ultima modifica:11 Novembre 2009 12:32

Solo per gli Amministratori dell'archivio: edita il record